TG Therapeutics Inc (TGTX)
13.66
+0.34
(+2.55%)
USD |
NASDAQ |
Apr 30, 16:00
14.30
+0.64
(+4.69%)
After-Hours: 20:00
TG Therapeutics Max Drawdown (5Y): 93.19% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 93.19% |
| March 31, 2024 | 93.19% |
| February 29, 2024 | 93.19% |
| January 31, 2024 | 93.19% |
| December 31, 2023 | 93.19% |
| November 30, 2023 | 93.19% |
| October 31, 2023 | 93.19% |
| September 30, 2023 | 93.19% |
| August 31, 2023 | 93.19% |
| July 31, 2023 | 93.19% |
| June 30, 2023 | 93.19% |
| May 31, 2023 | 93.19% |
| April 30, 2023 | 93.19% |
| March 31, 2023 | 93.19% |
| February 28, 2023 | 93.19% |
| January 31, 2023 | 93.19% |
| December 31, 2022 | 93.19% |
| November 30, 2022 | 93.19% |
| October 31, 2022 | 93.19% |
| September 30, 2022 | 93.19% |
| August 31, 2022 | 93.19% |
| July 31, 2022 | 93.19% |
| June 30, 2022 | 93.19% |
| May 31, 2022 | 91.95% |
| April 30, 2022 | 88.07% |
| Date | Value |
|---|---|
| March 31, 2022 | 85.77% |
| February 28, 2022 | 84.94% |
| January 31, 2022 | 84.94% |
| December 31, 2021 | 81.72% |
| November 30, 2021 | 81.72% |
| October 31, 2021 | 81.72% |
| September 30, 2021 | 81.72% |
| August 31, 2021 | 81.72% |
| July 31, 2021 | 81.72% |
| June 30, 2021 | 81.72% |
| May 31, 2021 | 81.72% |
| April 30, 2021 | 81.72% |
| March 31, 2021 | 81.72% |
| February 28, 2021 | 81.72% |
| January 31, 2021 | 81.72% |
| December 31, 2020 | 81.72% |
| November 30, 2020 | 81.72% |
| October 31, 2020 | 81.72% |
| September 30, 2020 | 81.72% |
| August 31, 2020 | 81.72% |
| July 31, 2020 | 81.72% |
| June 30, 2020 | 81.72% |
| May 31, 2020 | 81.72% |
| April 30, 2020 | 81.72% |
| March 31, 2020 | 81.72% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
81.72%
Minimum
Sep 2019
93.19%
Maximum
Jun 2022
86.93%
Average
84.94%
Median
Jan 2022
Max Drawdown (5Y) Benchmarks
| Amicus Therapeutics Inc | 74.97% |
| Geron Corp | 86.09% |
| Editas Medicine Inc | 94.24% |
| G1 Therapeutics Inc | 97.24% |
| Mersana Therapeutics Inc | 96.16% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -16.56 |
| Beta (5Y) | 2.328 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 110.0% |
| Historical Sharpe Ratio (5Y) | 0.0853 |
| Historical Sortino (5Y) | 0.196 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 40.46% |